Fig. 5From: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsThe scenario IV of three AEs with flat effect relationships and same effect for rest of AEs with safety issues under various non-decreasing incidence rate as dosage increases for eight arms. (The dashed line is the expected incidence rate for each AE)Back to article page